INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $598M invested in Infinity Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
–
Holders Change %
0%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
37
Reduced
32
Closed
13
Calls
$4.85M
Puts
$11.2M
Net Calls
-$6.38M
Net Calls Change
-$1.69M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.01M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.84M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.59M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$4.37M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.22M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$15M |
| 2 |
DM
Deerfield Management
New York
|
-$9.8M |
| 3 |
VAM
Visium Asset Management
New York
|
-$5.35M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.49M |
| 5 |
Renaissance Technologies
New York
|
-$3.82M |
